Cas no 1373870-41-7 (5-Methoxycarbonyl-1H-indole-2-boronic acid)
5-Methoxycarbonyl-1H-indole-2-boronic acid Chemical and Physical Properties
Names and Identifiers
-
- 5-METHOXYCARBONYL-1H-INDOLE-2-BORONIC ACID
- (5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid
- [5-(methoxycarbonyl)-1H-indol-2-yl]boronic acid
- 3256AJ
- NE63135
- SB33186
- (5-methoxycarbonyl-1H-indol-2-yl)boronic acid
- 5-Methoxycarbonyl-1H-indole-2-boronic acid
-
- MDL: MFCD11858382
- Inchi: 1S/C10H10BNO4/c1-16-10(13)6-2-3-8-7(4-6)5-9(12-8)11(14)15/h2-5,12,14-15H,1H3
- InChI Key: WBSFVUSUPWXUDY-UHFFFAOYSA-N
- SMILES: O(C)C(C1C=CC2=C(C=1)C=C(B(O)O)N2)=O
Computed Properties
- Exact Mass: 219.0702880 g/mol
- Monoisotopic Mass: 219.0702880 g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 16
- Rotatable Bond Count: 3
- Complexity: 274
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 82.6
- Molecular Weight: 219.00
5-Methoxycarbonyl-1H-indole-2-boronic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0064-1g |
5-Methoxycarbonyl-1H-indole-2-boronic acid |
1373870-41-7 | 97% | 1g |
3816.19CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0064-5g |
5-Methoxycarbonyl-1H-indole-2-boronic acid |
1373870-41-7 | 97% | 5g |
15264.76CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0064-500mg |
5-Methoxycarbonyl-1H-indole-2-boronic acid |
1373870-41-7 | 97% | 500mg |
2332.12CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0064-250mg |
5-Methoxycarbonyl-1H-indole-2-boronic acid |
1373870-41-7 | 97% | 250mg |
1594.32CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0064-100mg |
5-Methoxycarbonyl-1H-indole-2-boronic acid |
1373870-41-7 | 97% | 100mg |
1221.18CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 32R0064-50mg |
5-Methoxycarbonyl-1H-indole-2-boronic acid |
1373870-41-7 | 97% | 50mg |
1034.61CNY | 2021-05-07 | |
| eNovation Chemicals LLC | Y1124475-100mg |
5-Methoxycarbonyl-1H-indole-2-boronic acid |
1373870-41-7 | 95% | 100mg |
$240 | 2024-07-28 | |
| eNovation Chemicals LLC | Y1124475-250mg |
5-Methoxycarbonyl-1H-indole-2-boronic acid |
1373870-41-7 | 95% | 250mg |
$340 | 2024-07-28 | |
| eNovation Chemicals LLC | Y1124475-500mg |
5-Methoxycarbonyl-1H-indole-2-boronic acid |
1373870-41-7 | 95% | 500mg |
$455 | 2024-07-28 | |
| eNovation Chemicals LLC | Y1124475-1g |
5-Methoxycarbonyl-1H-indole-2-boronic acid |
1373870-41-7 | 95% | 1g |
$665 | 2024-07-28 |
5-Methoxycarbonyl-1H-indole-2-boronic acid Related Literature
-
Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315
-
Connor J. Taylor,Hikaru Seki,Friederike M. Dannheim,Mark J. Willis,Graeme Clemens,Brian A. Taylor,Thomas W. Chamberlain,Richard A. Bourne React. Chem. Eng., 2021,6, 1404-1411
-
Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
-
Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
Additional information on 5-Methoxycarbonyl-1H-indole-2-boronic acid
Comprehensive Overview of 5-Methoxycarbonyl-1H-indole-2-boronic acid (CAS No. 1373870-41-7)
5-Methoxycarbonyl-1H-indole-2-boronic acid (CAS No. 1373870-41-7) is a highly versatile boronic acid derivative widely utilized in pharmaceutical research, organic synthesis, and material science. This compound belongs to the indole boronic acid family, a class of molecules known for their pivotal role in Suzuki-Miyaura cross-coupling reactions, a cornerstone of modern synthetic chemistry. With its unique methoxycarbonyl and boronic acid functional groups, this molecule offers exceptional reactivity and selectivity, making it a valuable building block for drug discovery and advanced material development.
The growing interest in 5-Methoxycarbonyl-1H-indole-2-boronic acid is driven by its applications in targeted drug design, particularly in the development of kinase inhibitors and anticancer agents. Researchers are increasingly focusing on indole-based scaffolds due to their bioactivity and structural diversity. Recent studies highlight its potential in proteolysis-targeting chimeras (PROTACs), a cutting-edge therapeutic strategy gaining traction in oncology and neurodegenerative disease research. This aligns with the rising demand for small molecule modulators in precision medicine.
From a synthetic perspective, CAS No. 1373870-41-7 demonstrates remarkable stability under various reaction conditions, enabling its use in multi-step organic transformations. Its boronic acid moiety facilitates efficient C-C bond formation, while the indole core provides a platform for further functionalization. This dual functionality addresses key challenges in heterocyclic chemistry, where researchers often seek atom-economical and high-yielding methodologies. The compound’s compatibility with green chemistry principles further enhances its appeal in sustainable synthesis.
In material science, 5-Methoxycarbonyl-1H-indole-2-boronic acid contributes to the design of organic electronic materials, including OLEDs and conductive polymers. Its π-conjugated system and electron-withdrawing groups enable fine-tuning of optoelectronic properties, a critical factor in advancing flexible electronics and energy storage devices. This application resonates with current trends in renewable energy and smart materials, areas frequently searched by engineers and chemists alike.
Quality control and analytical characterization of CAS No. 1373870-41-7 involve advanced techniques such as HPLC, NMR spectroscopy, and mass spectrometry. These methods ensure high purity and batch-to-batch consistency, critical for reproducible research outcomes. Frequently asked questions (FAQs) in scientific forums often revolve around its storage conditions (typically under inert atmosphere at low temperatures) and solubility profiles (favoring polar aprotic solvents like DMSO or THF). Such practical insights are invaluable for laboratory workflows.
The commercial availability of 5-Methoxycarbonyl-1H-indole-2-boronic acid from specialized chemical suppliers has expanded its accessibility to academic and industrial researchers. Its structure-activity relationship (SAR) studies continue to uncover new pharmacological potentials, particularly in GPCR modulation and enzyme inhibition. As the scientific community explores fragment-based drug discovery, this compound’s molecular weight and hydrogen-bonding capacity position it as a promising candidate for lead optimization pipelines.
In summary, 5-Methoxycarbonyl-1H-indole-2-boronic acid (CAS No. 1373870-41-7) exemplifies the convergence of medicinal chemistry, catalysis, and materials innovation. Its multifaceted applications address pressing challenges in healthcare and technology, while its synthetic versatility aligns with the industry’s shift toward efficient and sustainable methodologies. Ongoing research will likely reveal even broader utilities for this remarkable compound.
1373870-41-7 (5-Methoxycarbonyl-1H-indole-2-boronic acid) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)